Microvascular effects of anaphylatoxins C3a and C5a
- PMID: 3871207
Microvascular effects of anaphylatoxins C3a and C5a
Abstract
The direct microvascular effects of human C3a and C5a were investigated by using hamster cheek pouches prepared for intravital microscopy. Topical application of 10 nM C3a resulted in pronounced microcirculatory alterations, characterized by vasoconstriction, platelet aggregation, and an increase in macromolecular leakage at postcapillary venules, as assessed by extravasation of intravascular fluorescein-labeled dextran (m.w. 150,000). Exposure of the preparation to 500 nM COOH-terminal octapeptide analogs of C3a resulted in a microvascular response almost identical to that of C3a, supporting the view that the active site of this anaphylatoxin resided within the COOH-terminal portion. Changes similar to those caused by C3a were also induced by 20 or 100 nM C5a and, in addition, the higher concentration of C5a caused accumulation of polymorphonuclear leukocytes (PMNL) in small venules and somewhat prolonged vascular leakage from venules exhibiting PMNL accumulation. Histamine was found to partially mediate the vascular leakage induced by C3a and the initial (first 5 min) permeability response to the high concentration of C5a, whereas the subsequent leakage induced by the latter anaphylatoxin was unaffected by mepyramine pretreatment. In neutropenic and mepyramine-treated animals exposed to the high concentration of C5a, a partial reduction of both the early and the subsequent vascular leakage was seen, indicating that accumulated PMNL play a role in the prolonged phase of leakage. The pronounced microvascular alterations induced by low concentrations of C3a and C5a strengthen the view that these anaphylatoxins act as mediators of inflammatory reactions in which the complement system is activated.
Similar articles
-
Pulmonary injury induced by C3a and C5a anaphylatoxins.Am J Pathol. 1980 Aug;100(2):327-48. Am J Pathol. 1980. PMID: 6967702 Free PMC article.
-
Human C5a des Arg increases vascular permeability.J Immunol. 1981 Dec;127(6):2376-80. J Immunol. 1981. PMID: 6170701
-
Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.J Pharmacol Exp Ther. 1984 Sep;230(3):749-54. J Pharmacol Exp Ther. 1984. PMID: 6332191
-
Anaphylatoxins: possible roles in disease.Complement. 1986;3(3):177-88. doi: 10.1159/000467894. Complement. 1986. PMID: 3026724 Review.
-
Structure and function of the anaphylatoxins.Springer Semin Immunopathol. 1984;7(2-3):193-219. doi: 10.1007/BF01893020. Springer Semin Immunopathol. 1984. PMID: 6387982 Review.
Cited by
-
Fabrication of Three-Dimensional Bioactive Composite Scaffolds for Hemostasis and Wound Healing.AAPS PharmSciTech. 2021 Apr 20;22(4):138. doi: 10.1208/s12249-021-02010-0. AAPS PharmSciTech. 2021. PMID: 33880661
-
Endotoxin-induced shock in the rat. A role for C5a.Am J Pathol. 1989 Sep;135(3):489-97. Am J Pathol. 1989. PMID: 2789475 Free PMC article.
-
Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension.Pulm Circ. 2019 May 24;10(1):2045894019856483. doi: 10.1177/2045894019856483. Online ahead of print. Pulm Circ. 2019. PMID: 31124398 Free PMC article.
-
In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes.Am J Pathol. 1989 Apr;134(4):755-60. Am J Pathol. 1989. PMID: 2650556 Free PMC article.
-
CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Haemorrhage (CLASH): study protocol for a randomised controlled phase II clinical trial.Trials. 2020 Nov 25;21(1):969. doi: 10.1186/s13063-020-04838-6. Trials. 2020. PMID: 33239044 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources